1. Market Research
  2. > Biotechnology
  3. > Biological Therapy Market Trends
  4. > Biological Therapy Analysis & Statistics, March 2017 (p2)

Biological Therapy Analysis & Statistics, March 2017 (p2)

24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Publishers

31-60 of about 900 reports

Purchase Reports From Reputable Market Research Publishers

US Market Report for Cellular Allografts 2017 - MedCore

US Market Report for Cellular Allografts 2017 - MedCore

  • $ 2995
  • Industry report
  • March 2017
  • by iData Research, Inc.

Description General Report Contents - Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends - Market Drivers & Limiters for each chapter segment - Competitive Analysis for each chapte ...

  • Industries : Biological Therapy
  • Countries : United States
Global Regenerative Medicine Partnering 2010-2017: Deal trends, players, financials and forecasts

Global Regenerative Medicine Partnering 2010-2017: Deal trends, players, financials and forecasts

  • $ 2995
  • Industry report
  • February 2017
  • by Currentpartnering

Summary The Global Regenerative Medicine Partnering 2010-2017: Deal trends, players, financials and forecasts report provides comprehensive understanding and unprecedented access to the regenerative medicine ...

  • Industries : Biological Therapy, Biotechnology, Pharmaceutical, Pathology, Healthcare, Therapy
  • Countries : United States, North America
Liver Dialysis Equipment - Medical Devices Pipeline Assessment, 2017

Liver Dialysis Equipment - Medical Devices Pipeline Assessment, 2017

  • $ 2500
  • Industry report
  • April 2017
  • by GlobalData

Liver Dialysis Equipment - Medical Devices Pipeline Assessment, 2017 Summary GlobalData’s Medical Devices sector report, “Liver Dialysis Equipment - Medical Devices Pipeline Assessment, 2017" provides ...

  • Industries : Dialysis Device, Medical Device
  • Countries : United States
Adult Respiratory Distress Syndrome Global Clinical Trials Review, H1, 2017

Adult Respiratory Distress Syndrome Global Clinical Trials Review, H1, 2017

  • $ 2500
  • Industry report
  • March 2017
  • by GlobalData

Adult Respiratory Distress Syndrome Global Clinical Trials Review, H1, 2017 Summary GlobalData’s clinical trial report, “Adult Respiratory Distress Syndrome Global Clinical Trials Review, H1, 2017" ...

  • Industries : Chronic Disease, Biological Therapy, Pathology, Therapy, Biotechnology
  • Countries : World
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Global Clinical Trials Review, H1, 2017

Adrenocortical Carcinoma (Adrenal Cortex Cancer) Global Clinical Trials Review, H1, 2017

  • $ 2500
  • Industry report
  • March 2017
  • by GlobalData

Adrenocortical Carcinoma (Adrenal Cortex Cancer) Global Clinical Trials Review, H1, 2017 Summary GlobalData’s clinical trial report, “Adrenocortical Carcinoma (Adrenal Cortex Cancer) Global Clinical ...

  • Industries : Cancer, Pathology, Therapy
  • Countries : World
Acute Respiratory Distress Syndrome Global Clinical Trials Review, H1, 2017

Acute Respiratory Distress Syndrome Global Clinical Trials Review, H1, 2017

  • $ 2500
  • Industry report
  • February 2017
  • by GlobalData

Acute Respiratory Distress Syndrome Global Clinical Trials Review, H1, 2017 Summary GlobalData’s clinical trial report, “Acute Respiratory Distress Syndrome Global Clinical Trials Review, H1, 2017” ...

  • Industries : Therapy, Biological Therapy, Biotechnology, Pharmaceutical, Biopharmaceutical
  • Countries : World
Acute Lung Injury Global Clinical Trials Review, H1, 2017

Acute Lung Injury Global Clinical Trials Review, H1, 2017

  • $ 2500
  • Industry report
  • February 2017
  • by GlobalData

Acute Lung Injury Global Clinical Trials Review, H1, 2017 Summary GlobalData’s clinical trial report, “Acute Lung Injury Global Clinical Trials Review, H1, 2017” provides an overview of Acute Lung ...

  • Industries : Chronic Disease, Biological Therapy, Pathology, Biotechnology
  • Countries : World
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Trials Review, H1, 2017

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Trials Review, H1, 2017

  • $ 2500
  • Industry report
  • February 2017
  • by GlobalData

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Trials Review, H1, 2017 Summary GlobalData’s clinical trial report, “Acute Myelocytic Leukemia (AML, Acute Myeloblastic ...

  • Industries : Drug Discovery and Development, Pharmaceutical
  • Countries : World, United States
Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H1, 2017

Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H1, 2017

  • $ 2500
  • Industry report
  • February 2017
  • by GlobalData

Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H1, 2017 Summary GlobalData’s clinical trial report, “Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical ...

  • Industries : Pharmaceutical, Drug Discovery and Development, Pathology, Therapy, Healthcare
  • Countries : World
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical Trials Review, H1, 2017

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical Trials Review, H1, 2017

  • $ 2500
  • Industry report
  • February 2017
  • by GlobalData

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical Trials Review, H1, 2017 Summary GlobalData’s clinical trial report, “Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic ...

  • Industries : Pharmaceutical, Drug Discovery and Development, Cancer, Pathology
  • Countries : World, United States
Abdominal Aortic Aneurysms Global Clinical Trials Review, H1, 2017

Abdominal Aortic Aneurysms Global Clinical Trials Review, H1, 2017

  • $ 2500
  • Industry report
  • February 2017
  • by GlobalData

Abdominal Aortic Aneurysms Global Clinical Trials Review, H1, 2017 Summary GlobalData’s clinical trial report, “Abdominal Aortic Aneurysms Global Clinical Trials Review, H1, 2017" provides an overview ...

  • Industries : General Medicine and Specialty Medicine
  • Countries : World
Cell Therapy Manufacturing Market, 2017-2027

Cell Therapy Manufacturing Market, 2017-2027

  • $ 2499
  • Industry report
  • March 2017
  • by Roots Analysis Private Ltd.

The “Cell Therapy Manufacturing Market, 2017-2027” report provides an extensive study of the rapidly growing market of cell therapy manufacturing and focuses both on contract manufacturers and cell ...

  • Industries : Biological Therapy, Biotechnology
  • Countries : United States, Europe, United Kingdom
Natural Killer Cells Therapies- Competitive Landscape,Technology and Pipeline Analysis, 2017

Natural Killer Cells Therapies- Competitive Landscape,Technology and Pipeline Analysis, 2017

  • $ 2450
  • Industry report
  • April 2017
  • by Delve Insight

DelveInsight’s report, “Natural Killer Cells Therapies- Competitive Landscape, Technology and Pipeline Analysis, 2017”, emphasizes on the currently active NK cell therapy products and NK cell augmenters ...

  • Industries : Therapy, Biological Therapy
Natural Killer Cells - Competitive Landscape, Pipeline and Market Analysis, 2017

Natural Killer Cells - Competitive Landscape, Pipeline and Market Analysis, 2017

  • $ 2450
  • Industry report
  • March 2017
  • by Delve Insight

DelveInsight’s, “Natural Killer Cells- Competitive Landscape, Pipeline and Market Analysis, 2017”, report provides comprehensive insights about marketed and pipeline drugs across this Mechanism of ...

  • Industries : Biological Therapy, Therapy
Global CAR  T Cell Therapy Market & Clinical Trials Insight 2022

Global CAR T Cell Therapy Market & Clinical Trials Insight 2022

  • $ 2400
  • Industry report
  • April 2017
  • by Kuick Research

“Global CAR T Cell Therapy Market & Clinical Trials Insight 2022” report highlights the ongoing clinical and non-clinical advancement in the field of Car T Cell Therapy. As per report findings, the ...

  • Industries : Biological Therapy, Therapy, Motor Vehicle
  • Countries : World
The Oncolytic Virus Landscape 2017: an analysis of pipeline, stakeholders, deals, industry trends & opportunities

The Oncolytic Virus Landscape 2017: an analysis of pipeline, stakeholders, deals, industry trends & opportunities

  • $ 2365
  • Industry report
  • January 2017
  • by La Merie Publishing

The Oncolytic Virus Landscape 2017: an analysis of pipeline,stakeholders, deals, industry trends & opportunities The field of oncolytic viruses wasquite dormant in the first decade of the 2000s, characterized ...

  • Industries : Pathology, Therapy, Cancer
  • Countries : United States
China Interferon Industry Report, 2016-2021

China Interferon Industry Report, 2016-2021

  • $ 2300
  • Industry report
  • April 2017
  • by Research In China

Interferon is mainly used for the treatment of hepatitis B, hepatitis C, multiple sclerosis, condyloma acuminatum and other diseases. Wherein, IFN-? is mainly suitable for curing hepatitis B and hepatitis ...

  • Industries : Biological Therapy
  • Countries : China
Liver Fibrosis - Pipeline Review, H1 2017

Liver Fibrosis - Pipeline Review, H1 2017

  • $ 2000
  • Company report
  • April 2017
  • by Global Markets Direct

Liver Fibrosis - Pipeline Review, H1 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Liver Fibrosis - Pipeline Review, H1 2017, provides an overview of ...

  • Industries : Pharmaceutical, Pathology, Therapy
  • Countries : United States, World
Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline Review, H1 2017

Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline Review, H1 2017

  • $ 2000
  • Company report
  • March 2017
  • by Global Markets Direct

Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) ...

  • Industries : Cancer, Pathology
  • Countries : United States
Myocardial Infarction - Pipeline Review, H1 2017

Myocardial Infarction - Pipeline Review, H1 2017

  • $ 2000
  • Company report
  • March 2017
  • by Global Markets Direct

Myocardial Infarction - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Myocardial Infarction – Pipeline Review, H1 2017, provides ...

  • Industries : Chronic Disease, Pathology
  • Countries : United States, World
Nasopharyngeal Cancer - Pipeline Review, H1 2017

Nasopharyngeal Cancer - Pipeline Review, H1 2017

  • $ 2000
  • Company report
  • March 2017
  • by Global Markets Direct

Nasopharyngeal Cancer - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Nasopharyngeal Cancer – Pipeline Review, H1 2017, provides ...

  • Industries : Cancer, Pathology, Therapy
  • Countries : United States
Juvenile Macular Degeneration (Stargardt Disease) - Pipeline Review, H1 2017

Juvenile Macular Degeneration (Stargardt Disease) - Pipeline Review, H1 2017

  • $ 2000
  • Company report
  • March 2017
  • by Global Markets Direct

Juvenile Macular Degeneration (Stargardt Disease) - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Juvenile Macular Degeneration – ...

  • Industries : Pathology, General Medicine and Specialty Medicine, Healthcare
  • Countries : United States
Epstein–Barr Virus (HHV-4) Infections - Pipeline Review, H1 2017

Epstein–Barr Virus (HHV-4) Infections - Pipeline Review, H1 2017

  • $ 2000
  • Company report
  • March 2017
  • by Global Markets Direct

Epstein–Barr Virus (HHV-4) Infections - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Epstein–Barr Virus (HHV-4) Infections – ...

  • Industries : Pathology
  • Countries : United States, World, United Kingdom
B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H1 2017

B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H1 2017

  • $ 2000
  • Company report
  • March 2017
  • by Global Markets Direct

B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide B-Cell Chronic Lymphocytic Leukemia – Pipeline ...

  • Industries : Cancer, Pathology
  • Countries : United States
Bronchopulmonary Dysplasia - Pipeline Review, H1 2017

Bronchopulmonary Dysplasia - Pipeline Review, H1 2017

  • $ 2000
  • Company report
  • March 2017
  • by Global Markets Direct

Bronchopulmonary Dysplasia - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Bronchopulmonary Dysplasia – Pipeline Review, H1 2017, ...

  • Industries : Therapy, Chronic Disease
  • Countries : United States
Duchenne Muscular Dystrophy - Pipeline Review, H1 2017

Duchenne Muscular Dystrophy - Pipeline Review, H1 2017

  • $ 2000
  • Company report
  • March 2017
  • by Global Markets Direct

Duchenne Muscular Dystrophy - Pipeline Review, H1 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Duchenne Muscular Dystrophy - Pipeline Review, H1 2017, ...

  • Industries : Pathology, Mental Health, Therapy, Pharmaceutical
  • Countries : United States
Thalassemia - Pipeline Review, H1 2017

Thalassemia - Pipeline Review, H1 2017

  • $ 2000
  • Company report
  • March 2017
  • by Global Markets Direct

Thalassemia - Pipeline Review, H1 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Thalassemia - Pipeline Review, H1 2017, provides an overview of the ...

  • Industries : Pathology, Healthcare
  • Countries : United States
Liver Cirrhosis - Pipeline Review, H1 2017

Liver Cirrhosis - Pipeline Review, H1 2017

  • $ 2000
  • Company report
  • March 2017
  • by Global Markets Direct

Liver Cirrhosis - Pipeline Review, H1 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Liver Cirrhosis - Pipeline Review, H1 2017, provides an overview ...

  • Industries : Pathology
  • Countries : United States
Bone Marrow Transplant Rejection - Pipeline Review, H1 2017

Bone Marrow Transplant Rejection - Pipeline Review, H1 2017

  • $ 2000
  • Company report
  • March 2017
  • by Global Markets Direct

Bone Marrow Transplant Rejection - Pipeline Review, H1 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Bone Marrow Transplant Rejection - Pipeline Review, ...

  • Industries : Healthcare, Blood Supply, Tissue Banking and Transplantation, Health Facility, Therapy
  • Countries : United States
Congestive Heart Failure (Heart Failure) - Pipeline Review, H1 2017

Congestive Heart Failure (Heart Failure) - Pipeline Review, H1 2017

  • $ 2000
  • Company report
  • March 2017
  • by Global Markets Direct

Congestive Heart Failure (Heart Failure) - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Congestive Heart Failure (Heart Failure) ...

  • Industries : Chronic Disease, Pathology
  • Countries : United States

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.